Inventor · disambiguated record
Nobuyuki Takakura
Also filed as: TAKAKURA NOBUYUKI
19 granted patents·7 pending applications·62 citations·filing 2001–2025
91Inventor score
Files withUNIV OSAKA8TAKEDA PHARMACEUTICALS CO6TAKAKURA NOBUYUKI2TAKEDA PHARMACEUTICAL2YASUMA TSUNEO2
Top patents by PatentIndex Score
26 records- 0187US8535943B2Blood platelet induction methodNAKANO YASUHIRO·Filed 2009·Granted Sep 17, 2013·9 cites·11 claims
- 0285US11186565B2Aromatic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Nov 30, 2021·3 cites·10 claims
- 0384US7368578B2Five-membered heterocyclic compoundsTAKEDA PHARMACEUTICAL·Filed 2003·Granted May 6, 2008·17 cites·12 claims
- 0481US7238716B2Alkanoic acid derivatives process for their production and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2001·Granted Jul 3, 2007·17 cites·9 claims
- 0580US12312603B2Cell populations of CD31-positive, CD45-negative, CD200-positive mammalian cells and use thereofUNIV OSAKA·Filed 2024·Granted May 27, 2025·0 cites·16 claims
- 0672US2025257326A1Cell populations of cd31-positive, cd45-negative, cd200-positive mammalian cells and use thereofUNIV OSAKA·Filed 2025·Application pending·0 cites
- 0770US9776962B2Aromatic compounds with GPR40 agonistic activityTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Oct 3, 2017·2 cites·16 claims
- 0865US9605000B2Spiro azetidine isoxazole derivatives and their use as SSTR antagonistsTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Mar 28, 2017·1 cites·12 claims
- 0965US8937055B2Heterocyclic ring compound having muscle cell or adipocyte differentiation regulating actionUJIKAWA OSAMU·Filed 2011·Granted Jan 20, 2015·2 cites·11 claims
- 1063US11920161B2Cell populations of CD31-positive, CD45-negative, CD200-positive mammalian cells and use thereofUNIV OSAKA·Filed 2018·Granted Mar 5, 2024·0 cites·12 claims
- 1163US9320770B2Blood vessel maturation, normalization or stabilization agent and wrinkle preventer/improverOTA MASAHIRO·Filed 2009·Granted Apr 26, 2016·1 cites·4 claims
- 1263US8093047B2Induction of myocardial cell from mammalian bone marrow cell or cord blood-derived cell and fat tissueTAKAKURA NOBUYUKI·Filed 2004·Granted Jan 10, 2012·10 cites·10 claims
- 1354US8557805B2Fused ring compound and use thereofYASUMA TSUNEO·Filed 2009·Granted Oct 15, 2013·0 cites·21 claims
- 1453US11802135B2Lysophosphatidic acid derivativeMITSUBISHI TANABE PHARMA CORP·Filed 2021·Granted Oct 31, 2023·0 cites·16 claims
- 1552US11952344B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Apr 9, 2024·0 cites·5 claims
- 1652US8673942B2Fused ring compounds and use thereofYASUMA TSUNEO·Filed 2009·Granted Mar 18, 2014·0 cites·13 claims
- 1752US2021205337A1Drug delivery enhancer comprising substance for activating lysophospholipid receptorsUNIV OSAKA·Filed 2020·Application pending·0 cites
- 1849US2007197532A1Glucokinase activatorsCAO SHELDON X·Filed 2006·Application pending·0 cites
- 1948US10968231B2Substituted cyclyl-acetic acid derivatives for the treatment of metabolic disordersTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Apr 6, 2021·0 cites·10 claims
- 2045US11033559B2Leukocyte infiltration promoting agent and antitumor immunostimulatory agentUNIV OSAKA·Filed 2016·Granted Jun 15, 2021·0 cites·13 claims
- 2145US2022275343A1Method for producing vascular endothelial stem cellUNIV OSAKA·Filed 2020·Application pending·0 cites
- 2244US2011070297A1Glucokinase activatorsTAKEDA SAN DIEGO INC·Filed 2010·Application pending·0 cites
- 2340US12447165B2Intratumoral vein-formation promoting agentUNIV OSAKA·Filed 2017·Granted Oct 21, 2025·0 cites·4 claims
- 2440US9238639B2Aromatic ring compoundTAKEDA PHARMACEUTICAL·Filed 2013·Granted Jan 19, 2016·0 cites·8 claims
- 2532US2012270922A1Antiangiogenic Agent and Method for Inhibition of AngiogenesisTAKAKURA NOBUYUKI·Filed 2010·Application pending·0 cites
- 2631US2017112861A1Drug delivery enhancer comprising substance for activating lysophospholipid receptorsUNIV OSAKA·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nobuyuki Takakura files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →